Closed Public Consultation: Designated Drugs Regulation
Note: This public consultation is now closed.
On May 30, 2019, the College of Midwives of Ontario (College) received a letter from the Health Minister Christine Elliott requesting that the College amend its Designated Drugs Regulation made under the Midwifery Act, 1991 to include categories of drugs and substances.
The College’s current Designated Drugs Regulation includes lists of individual drugs and substances that can be prescribed or administered by injection or inhalation on midwife’s own authority.
The College was requested to undertake this work immediately with a view that the formal submission to the Ministry should be made no later than December 31, 2019.
What will change?
The College is proposing the following amendments to the Designated Drugs Regulation:
- Rescind lists of drugs and substances in the current Designated Drugs Regulation and include categories of drugs and substances in accordance with the American Hospital Formulary Services (AHFS) pharmacologic-therapeutic classification categories.
- Make it a condition of registration that all members and midwifery applicants must successfully complete, within a time period specified by Council, a mandatory training approved by Council relating to the safe, effective, and ethical prescription and administration of controlled substances.
- Enable midwives, in the course of engaging in the practice of midwifery, to prescribe any drug and administer any substance by injection or inhalation on the order of a physician and a nurse practitioner.
The College’s Council has reviewed the proposed draft of the Designated Drugs Regulation at its September 20, 2019, meeting and made a decision to circulate the draft for a 60-day consultation.
What are the AHFS pharmacologic-therapeutic classification categories?
What AHFS categories does the College propose to include in the amended regulation?
When will the regulation be approved?
What happened to the College’s previous submission requesting broad prescribing and administering?
We invite midwives, stakeholders, and members of the public to comment on the proposed changes to the Designated Drugs Regulation below.
You are welcome to share any comments you might have. It will be helpful if in addition to your general comments, you could also address the following question:
After reviewing the proposed categories (and individual drugs and substances that fall under these categories), what additional drugs or substances should be included and what will they be used to treat?
Our consultation is open until Friday, November 22, 2019, and all members of the public, stakeholders, and midwives are invited to share their thoughts below.
Thank you for taking the time to read and provide your comments. We will carefully consider your feedback. We greatly appreciate your participation and contribution to this initiative.
Please note that all comments are reviewed before being posted publicly to ensure they meet the Posting Guidelines. If you prefer to provide feedback via email, please email email@example.com with “Proposed Amendments to the Designated Drugs Regulation” in the subject line.